| Primary |
| Asthma |
40.4% |
| Product Used For Unknown Indication |
33.3% |
| Chronic Obstructive Pulmonary Disease |
9.0% |
| Drug Use For Unknown Indication |
3.4% |
| Bronchitis |
2.5% |
| Respiratory Disorder |
2.0% |
| Bronchospasm |
1.1% |
| Cough |
1.1% |
| Dyspnoea |
1.1% |
| Productive Cough |
1.1% |
| Emphysema |
0.8% |
| Multiple Allergies |
0.8% |
| Back Disorder |
0.6% |
| Contraception |
0.6% |
| Hypothyroidism |
0.6% |
| Bronchial Hyperreactivity |
0.3% |
| Bronchial Obstruction |
0.3% |
| Diabetes Mellitus |
0.3% |
| Disease Recurrence |
0.3% |
| Dyspnoea Exertional |
0.3% |
|
| Product Quality Issue |
19.7% |
| Drug Ineffective |
11.1% |
| Asthma |
10.1% |
| Dyspnoea |
9.6% |
| Drug Administration Error |
6.7% |
| Vomiting |
5.8% |
| Wheezing |
5.3% |
| Pneumonia |
4.8% |
| Inhalation Therapy |
4.3% |
| Pharmaceutical Product Complaint |
2.9% |
| Death |
2.4% |
| Hospitalisation |
2.4% |
| Malaise |
2.4% |
| Throat Tightness |
2.4% |
| Oxygen Saturation Decreased |
1.9% |
| Product Substitution Issue |
1.9% |
| Surgery |
1.9% |
| Cough |
1.4% |
| Gait Disturbance |
1.4% |
| Heart Rate Increased |
1.4% |
|
| Secondary |
| Product Used For Unknown Indication |
46.9% |
| Asthma |
18.5% |
| Chronic Obstructive Pulmonary Disease |
11.0% |
| Emphysema |
4.5% |
| Ill-defined Disorder |
3.5% |
| Analgesia |
3.1% |
| Foetal Exposure During Pregnancy |
2.4% |
| Drug Use For Unknown Indication |
2.0% |
| Analgesic Therapy |
1.6% |
| Respiratory Tract Infection |
1.2% |
| Bronchitis |
1.0% |
| Pneumonia |
0.8% |
| Asthma Exercise Induced |
0.6% |
| Bronchospasm |
0.6% |
| Respiratory Disorder |
0.6% |
| Dyspnoea |
0.4% |
| Immunisation |
0.4% |
| Rheumatoid Arthritis |
0.4% |
| Wheezing |
0.4% |
| Blood Cholesterol Increased |
0.2% |
|
| Death |
21.4% |
| Pneumonia |
11.7% |
| Dyspnoea |
6.8% |
| Hospitalisation |
6.8% |
| Product Quality Issue |
5.8% |
| Malaise |
4.9% |
| Chronic Obstructive Pulmonary Disease |
3.9% |
| Drug Ineffective |
3.9% |
| Spinal Fusion Surgery |
3.9% |
| Treatment Noncompliance |
3.9% |
| Wheezing |
3.9% |
| Adverse Event |
2.9% |
| Asthma |
2.9% |
| Condition Aggravated |
2.9% |
| Drug Administration Error |
2.9% |
| Myocardial Infarction |
2.9% |
| Neoplasm Malignant |
2.9% |
| Cardiac Arrest |
1.9% |
| Cataract |
1.9% |
| Dizziness |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.9% |
| Asthma |
12.4% |
| Chronic Obstructive Pulmonary Disease |
9.2% |
| Pain |
5.4% |
| Hypertension |
5.2% |
| Drug Use For Unknown Indication |
4.8% |
| Depression |
2.6% |
| Anxiety |
2.5% |
| Dyspnoea |
2.2% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Wheezing |
1.8% |
| Diabetes Mellitus |
1.7% |
| Prophylaxis |
1.7% |
| Nausea |
1.5% |
| Cough |
1.5% |
| Rheumatoid Arthritis |
1.5% |
| Bronchitis |
1.3% |
| Osteoporosis |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Contraception |
1.2% |
|
| Dyspnoea |
13.2% |
| Product Quality Issue |
8.7% |
| Wheezing |
8.7% |
| Drug Ineffective |
8.0% |
| Pulmonary Embolism |
6.6% |
| Asthma |
5.9% |
| Pain |
5.4% |
| Chronic Obstructive Pulmonary Disease |
4.5% |
| Pneumonia |
4.5% |
| Death |
4.2% |
| Vomiting |
3.8% |
| Nausea |
3.3% |
| Oedema Peripheral |
3.3% |
| Weight Decreased |
3.3% |
| Weight Increased |
3.3% |
| Malaise |
2.8% |
| Off Label Use |
2.8% |
| Dysphonia |
2.6% |
| Rash |
2.6% |
| Cough |
2.4% |
|
